CENTUPLE GLOBAL LIMITED

BSE: CENTUPLE531099ISIN INE396H01019

Healthcare
Pharmaceuticals

Share price

₹33.89-0.50 (-1.45%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹144.40
52W low: ₹28.42
Off 52W high: -76.53%
1M return: +3.17%
3M return: -14.33%
6M return: -14.70%
1Y return: -52.25%
20D avg volume: 2,617
50 DMA: ₹34.10
200 DMA: ₹52.12

Key ratios Standalone

Market cap: ₹18.53 Cr
Current price: ₹33.89
52W high / low: ₹144.40 / ₹28.42
Face value: ₹10.00
P/E: 15.00
P/B: 36.05
EPS (TTM): ₹2.26
Book value / share: ₹0.94
ROE: 240.64%
ROCE: 9.80%
Operating margin: —
Net margin: —
Debt / equity: 3.26
Net debt: ₹6.65 Cr
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 20.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.00	279.42	174.09	108.59	11.71	0.25	0.10	0.05	0.10	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	0.00	279.42	174.09	108.59	11.71	0.25	0.10	0.05	0.10	—
	0.18	279.79	173.32	106.80	11.62	0.16	0.14	0.08	0.07	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	279.16	172.69	107.03	11.45	0.00	—	—	—	—
	0.02	0.08	0.06	0.09	0.07	0.06	0.11	0.07	0.03	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	0.00	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.16	0.55	0.57	0.77	0.11	0.10	0.03	0.01	0.04	—
	-0.18	-0.37	0.77	1.80	0.09	0.09	-0.04	-0.03	0.03	—
	0.00	0.00	0.00	0.00	0.00	-0.02	0.02	—	—	—
	-0.18	-0.37	0.77	1.80	0.09	0.07	-0.02	-0.03	0.03	—
	0.00	0.11	0.19	0.47	0.00	0.01	—	0.01	—	—
	-0.18	-0.48	0.57	1.32	0.09	0.06	-0.02	-0.04	0.03	—
	-0.04	0.18	1.05	2.42	0.16	0.12	-0.01	-0.08	0.05	—
Key metrics
	-0.18	-0.37	0.77	1.80	0.09	0.07	-0.02	-0.03	0.03	—
	—	-0.10%	0.40%	1.70%	0.80%	28.00%	-20.00%	-60.00%	30.00%	—
	—	-0.20%	0.30%	1.20%	0.80%	24.00%	-20.00%	-80.00%	30.00%	—
	—	-1.60%	—	91.40%	—	12.50%	—	—	—	—
	-100.00%	1,11,668.00%	1,73,990.00%	2,17,080.00%	11,610.00%	—	—	—	—	—
	-300.00%	-900.00%	2,950.00%	3,400.00%	200.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	562.10	573.81	0.50	—
	0.00	0.00	0.00	—
	562.10	573.81	0.50	—
	560.09	571.53	0.45	—
	0.00	0.00	0.00	—
	558.88	570.33	0.00	—
	0.25	0.29	0.26	—
	0.00	0.00	0.00	—
	0.00	0.00	0.01	—
	2.05	2.00	0.18	—
	2.02	2.28	0.05	—
	0.00	0.00	0.00	—
	2.02	2.28	0.05	—
	0.77	0.78	0.02	—
	1.23	1.51	0.03	—
	3.61	5.52	0.05	—
Key metrics
	2.02	2.28	0.06	—
	0.36%	0.40%	12.00%	—
	0.22%	0.30%	6.00%	—
	—	9.80%	8.90%	—
	4,541.62%	1,14,662.00%	—	—
	1,266.67%	4,933.30%	—	—
	—	-28.03	0.19	—
	—	-18.55	6.33	—
	—	3.26	0.00	—
	—	6.65	-0.03	—
	—	20.5	0.0	—
Balance sheet
	—	342.90	0.65	—
	—	342.89	0.37	—
	—	0.09	0.03	—
	—	337.73	0.00	—
	—	1.10	0.00	—
	—	3.85	0.03	—
	—	0.02	0.00	—
	—	306.55	0.00	—
	—	319.67	0.09	—
	—	6.74	0.00	—
	—	6.74	0.00	—
	—	0.00	0.00	—
	—	2.07	0.56	—
Cash flow
	—	-28.01	0.19	—
	—	0.18	-0.18	—
	—	27.90	0.00	—
	—	0.02	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +4,541.62%
Profit YoY (TTM): +1,266.67%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 0.00%

Quarter	September 2026	June 2026
Promoter %	0.00%	0.00%

Holder	Type	Holding	Previous	Change
NOVA GLOBAL OPPORTUNITIES FUND PCC - BLUESTONE	Public	9.47%	—	—
RELIGARE FINVEST LTD	Public	5.89%	5.89%	0.00%
M7 GLOBAL FUND PCC-CELL DEWCAP FUND	Public	5.81%	5.48%	+0.33%
ZEAL GLOBAL OPPORTUNITIES FUND	Public	3.86%	—	—
RAKESH BAID	Public	3.66%	3.66%	0.00%
GATRAJ JAIN	Public	3.66%	3.66%	0.00%
CHARU MEHRA	Public	3.33%	3.33%	0.00%
ADITYA BAID	Public	2.93%	2.93%	0.00%
PRADEEP SAXENA	Public	2.79%	2.79%	0.00%
MEENA BAID	Public	2.74%	2.74%	0.00%
AMAN BAID	Public	1.83%	1.83%	0.00%
MALINI PRADEEP SAXENA	Public	1.77%	1.77%	0.00%
SURENDRA SINGH KUSHWAH	Public	1.50%	—	—
BINAIKUMAR SURESH PRASAD SAXENA	Public	1.12%	1.12%	0.00%
CHANDRAPRAKASH JAMNALAL KABRA	Public	1.01%	1.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
CENTUPLE GLOBAL LIMITED S	19	33.89	15.00	9.80%	+4,541.62% TTM	+1,266.67% TTM	-52.25%

Filings & corporate actions

Recent announcements

Newspaper publication - Notice of Postal Ballot15 Oct 2026 · Company Update / Newspaper Publication
Notice of postal ballot13 Oct 2026 · AGM/EGM / Postal Ballot
Outcome of Board meeting12 Oct 2026 · Board Meeting / Outcome of Board Meeting
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve Intimation of board meeting8 Oct 2026 · Board Meeting / Board Meeting
Compliance certificate for the quarter ended September 30, 20266 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Scrutinizer Report1 Oct 2026 · AGM/EGM / AGM
Outcome of AGM1 Oct 2026 · AGM/EGM / AGM
Proceeding of the 35th AGM30 Sep 2026 · AGM/EGM / AGM
Outcome of Board Meeting24 Sep 2026 · Board Meeting / Outcome of Board Meeting
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/09/2026 ,inter alia, to consider and approve the appointment of a Whole-Time Director22 Sep 2026 · Board Meeting / Board Meeting
Closure of trading window21 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication8 Sep 2026 · Company Update / Newspaper Publication
Annual Report 20265 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of AGM5 Sep 2026 · AGM/EGM / AGM
Outcome of Board Meeting5 Sep 2026 · Board Meeting / Outcome of Board Meeting
Annual Secretariral Compliance Report for the year ended March 31, 202627 Aug 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve Intimation of board meeting27 Aug 2026 · Board Meeting / Board Meeting
Compliace certificate under regulation 74 for the quarter ended June 30, 202626 Aug 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Newspaper publication18 Aug 2026 · Company Update / Newspaper Publication
Resignation of statutory auditor14 Aug 2026 · Company Update / Resignation of Statutory Auditors
Outcome of board meeting13 Aug 2026 · Result / Financial Results
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To approve the Unaudited ....4 Aug 2026 · Board Meeting / Board Meeting
Resignation of Ms. Shruti gupta as Non-executive Independent Director13 Jul 2026 · Company Update / Resignation of Director
Closure of trading window in connection with unaudited financial result for the quarter ended June 30, 202623 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Scrutinizer report of EGM20 Jun 2026 · AGM/EGM / EGM
Outcome of EGM19 Jun 2026 · AGM/EGM / EGM
EGM Proceeding18 Jun 2026 · AGM/EGM / EGM
Newspaper publication2 Jun 2026 · Company Update / Newspaper Publication
Audited financial result for the quarter and year ended March 31, 202630 May 2026 · Result / Financial Results
Outcome of Board Meeting30 May 2026 · Board Meeting / Outcome of Board Meeting
Resignation of Director26 May 2026 · Company Update / Resignation of Director
Submission of newspaper publication of EGM26 May 2026 · Company Update / Newspaper Publication
Notice of EGM25 May 2026 · AGM/EGM / EGM
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Intimation of board meeting25 May 2026 · Board Meeting / Board Meeting
Outcome of Board Meeting23 May 2026 · Board Meeting / Outcome of Board Meeting
Intimation of board meeting23 May 2026 · Company Update / General
Centuple Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve Resignation of Secretarial ....20 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....29 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....29 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Clarification on Price Movement of Equity Shares24 Apr 2026 · Company Update / General

Board meetings

13 Aug 2026 Board Meeting - Financial Results